PPI network analysis revealed interactions among the above shared targets, leading to the identification of 38 shared genes that could serve as potential therapeutic targets for CRC, including TP53, IGFBP3, MYC, MMP1, MMP2, AKT2, EGFR, and TNF. Here, TP53 is linked to colorectal carcinoma.